Screener
Xeris Biopharma Holdings, Inc. XERS PP&E (Net)
PP&E (Net) at other companies
Other financials
Where this comes from
Reported directly by Xeris Biopharma Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The source filing: Xeris Biopharma Holdings, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:07 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001867096-26-000065
| Assets | June 30, 2026 / (unaudited) | December 31, 2025 |
|---|---|---|
| Inventory, net | 80,930 | 68,673 |
| Prepaid expenses and other current assets | 13,975 | 9,548 |
| Total current assets | 274,757 | 240,313 |
| Property and equipment, net | 4,834 | 4,945 |
| Operating lease right-of-use assets | 21,773 | 22,112 |
| Goodwill | 22,859 | 22,859 |
| Intangible assets, net | 82,657 | 88,078 |
| Other assets | 5,025 | 5,220 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Xeris Biopharma Holdings, Inc.'s PP&E (net)?
- Xeris Biopharma Holdings, Inc. (XERS) reported PP&E (net) of $4.83M in Q2 2026.
- How has Xeris Biopharma Holdings, Inc.'s PP&E (net) changed year-over-year?
- Xeris Biopharma Holdings, Inc.'s PP&E (net) decreased by 8.5% year-over-year, from $5.28M to $4.83M.
- What is the long-term trend for Xeris Biopharma Holdings, Inc.'s PP&E (net)?
- Over 5 years (2020 to 2025), Xeris Biopharma Holdings, Inc.'s PP&E (net) has grown at a -5.9% compound annual growth rate (CAGR), from $6.71M to $4.95M.
- What does PP&E (net) mean?
- Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.
Ask your AI about Xeris Biopharma Holdings, Inc.'s pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude